Dana Schorer
About Dana Schorer
Dana Schorer serves as the Vice President of Global Business Development at Genomind, a position she has held since 2018. She has a background in business development, having previously worked at Sequenom in various roles, including Director of International Commercial Operations and Senior Business Development Manager.
Work at Genomind
Dana Schorer has been serving as the Vice President of Global Business Development at Genomind since 2018. In this role, she is responsible for driving the company's global business strategies and expanding its market presence. Prior to her current position, she held the role of Director of Global Business Development at Genomind from 2016 to 2018, where she contributed to the company's growth initiatives. Her tenure at Genomind reflects a commitment to advancing the company's objectives in the mental health and genomics sectors.
Previous Experience at Sequenom
Before joining Genomind, Dana Schorer worked at Sequenom in various capacities. She was the Director of International Commercial Operations for Sequenom Laboratory for a period of six months in 2016. Additionally, she served as the Senior Business Development Manager at Sequenom Laboratories from 2012 to 2014. In these roles, she focused on developing international business strategies and enhancing operational efficiencies within the company.
Education and Expertise
Dana Schorer earned a Bachelor of Arts (B.A.) degree in English/Journalism from Lehigh University. Her educational background has equipped her with strong communication skills and a comprehensive understanding of business development strategies. This foundation has been instrumental in her career, particularly in her roles focused on global business development and commercial operations.
Professional Background
Dana Schorer has built a diverse professional background in business development within the healthcare and genomics industries. Her career spans over a decade, during which she has held significant positions at both Genomind and Sequenom. Her experience includes strategic planning, market expansion, and operational management, contributing to her expertise in driving business growth.